Effects of early and late antihypertensive treatment on extracellular matrix proteins and mononuclear cells in uninephrectomized SHR

Kidney International

Volumn 51, Issue 3, 1997, Pages 750-761

  Geiger, Helmut ^a   Fierlbeck, Wolfgang ^b   Mai, Monika ^b   Ruchti, Herbert ^b   Schönfeld, Volker ^b   Dämmrich, Jobst ^b   Hugo, Christian ^b   Neumayer, Hans H ^b  

^a GOETHE UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 4 [2' (1H TETRAZOL 5 YL)BIPHENYL 4 YLMETHOXY]QUINOLINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL;

ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HYPERTENSION; INTRAGASTRIC DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; UNINEPHRECTOMY;

EID: 0030928848     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.106     Document Type: Article

References (52)

1. DWORKIN LD, FEINER HD, PARKER M, TOLBERT E: Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR. Kidney Int 39:1112-1117, 1991
2. BRUNNER HR, NUSSBERGER J, WAEBER B: Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system. J Hypertens 11(Suppl 3):S53-S58, 1993
3. MAI M, GEIGER H, HILGERS KF, VEELKEN R, MANN JFE, DÄMMRICH J, LUFT FC: Early interstitial changes in hypertension-induced renal injury. Hypertension 22:754-765, 1993
4. WEISSTUCH JM, DWORKIN LD: Does essential hypertension cause end-stage renal disease? Kidney Int 41(Suppl 36):S33-S37, 1992
5. STERZEL RB, LUFT FC, GAO Y, SCHNERMANN J, BRIGGS JP, GANTEN D, WALDHERR R, SCHNABEL E, KRIZ W: Renal disease and the development of hypertension in salt-sensitive Dahl rats. Kidney Int 33:1119-1129, 1988
6. BOHLE A, GLOMB D, GRUND KE, MACKENSEN S: Correlation between relative interstitial volume of the renal cortex and serum creatinine concentration in minimal changes with nephrotic syndrome and in focal sclerosing glomerulonephritis. Virchows Arch 376:221-232, 1977
7. KENNER CH, EVAN AP, BLOMGREN P, ARONOFF GR, LUFT FC: Effect of protein intake on renal function and structure in partially nephrectomized rats. Kidney Int 27:739-750, 1985
8. KUNCIO GS, NEILSON EG, HAVERTY T: Mechanisms of tubulointerstitial fibrosis. Kidney Int 39:550-556, 1991
9. YEE J, KUNCIO GS, NEILSON EG: Tubulointerstitial injury following glomerulonephritis. Semin Nephrol 11:361-366, 1991
10. NATH KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20:1-17, 1992
11. COUSER WG, JOHNSON RJ: Mechanisms of progressive renal disease in glomerulonephritis. Am J Kidney Dis 23:193-198 1994
12. WEIBEL ER: Stereologic principles for morphometry in electron microscopy. Int Rev Cytol 26:235-302, 1969
13. BENNETT WM, WALKER RG, KINCAID-SMITH P: Renal cortical interstitial volume in mesangial IgA nephropathy. Lab Invest 47:330-335, 1982
14. KURKI P, VANDERLAAN M, DOLBEARE F, GRAY J, TAN EM: Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res 166:209-219, 1986
15. GANTEN D, SCHELLLING P, HOFFMANN WE, PHILLIPS MI, GANTEN U: The measurement of extrarenal isorenins, in Radioimmunoassay-Renin-Angiotensin, edited by KRAUSE DK, HUMMERICH W, POULSEN K, Stuttgart, Thieme 1978, pp 145-155
16. HALL PA, LEVISON DA, WOODS AL, YU CCW, KELLOCK DB, WATKINS JA, BARNES DM, GILLETT CE, CAMPLEJOHN R, DOVER R, WASEEM NH, LANE DP: Proliferating cell nuclear antigen (PCNA) immuno-localization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162:285-294, 1990
17. WESTENEND PJ, SMITS JF, STRUYKER-BOUDIER HAJ, WEENING JJ: Acute renal vascular response to ACE inhibition in two rat strains with different susceptibility to the development of glomerulosclerosis. Nephrol Dial Transplant 7:602-607, 1992
18. BEUKERS JJB, VAN DER WAL A, HOEDEMAEKER PJ, WEENING JJ: Converting enzyme inhibition and progressive glomerulosclerosis in the rat. Kidney Int 32:794-800, 1987
19. BABOOLAL K, MEYER TW: The effect of acute angiotensin II blockade on renal function in rats with reduced renal mass. Kidney Int 46:980-985, 1994
20. RECKELHOFF JF, SAMSELL L, DEY R, RACUSEN L, BAYLIS C: The effect of aging on glomerular hemodynamics in the rat. Am J Kidney Dis 20:70-75, 1992
21. ANDERSON S, RENNKE HG, SANTOS MM, PADILHA RM, ZATZ R: Glomerular adaptation with normal aging and with longtErm converting enzyme inhibitor (CEI) therapy. (abstract) Kidney Int 37:498, 1990
22. ICHIKAWA I, HARRIS RC: Angiotensin actions in the kidney: Renewed insight into old hormone. Kidney Int 40:583-596, 1991
23. CRARY GS, SWAN SK, O'DONNELL MP, KASISKE BL, KATZ SA, KEANE WF: The angiotensin II receptor antagonist losartan reduces blood pressure but not renal injury in obese Zucker rats. J Am Soc Nephrol 6:1295-1299, 1995
24. RAIJ L: Effects of ACE inhibitors and calcium channel blockers on the development of glomerular sclerosis in models of renal damage. Nephrol Dial Tranplant 10(Suppl 9):23-27, 1995
25. HOLLENBERG NK, RAIJ L: Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy. Arch Int Med 153:2426-2435, 1993
26. WOLF G, NEILSON EG: Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol 259:F768-F777, 1990
27. WOLF G, HABERSTROH U, NEILSON EG: Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140:95-107, 1992
28. PANIZO A, PARDO J, HERNANDEZ M, GALINDO MF, CENARRUZABEITIA E, DIEZ J: Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats. Am J Hypertens 8:815-822, 1995
29. KIM S, OHTA K, HAMAGUCHI A, OMURA T, YUKIMURA T, MIURA K, INADA Y, WADA T, ISHIMURA Y, CHATANI F, IWAO H: Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury. Kidney Int 46:1346-1358, 1994
30. KAKINUMA Y, KAWAMURA T, BILLS T, YOSHIOKA T, ICHIKAWA I, FOGO A: Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int 42:46-55, 1992
31. LAFAYETTE RA, MAYER G, PARK SK, MEYER TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90:766-771, 1992
32. POLLOCK DM, DIVISH BJ, POLAKOWSKI JS, OPGENORTH TJ: Angiotensin II receptor blockade improves renal function in rats with reduced renal mass. J Pharmacol Exp Ther 267:657-663, 1993
33. MACKENZIE HS, TROY JL, RENNKE HG, BRENNER BM: TCV prevents progressive renal injury in rats with extensive renal mass ablation. J Hypertens 12(Suppl 9):S11-S16, 1994
34. KOHARA K, MIKAMI H, OKUDA N, HIGAKI J, OGIHARA T: Angiotensin blockade and the progression of renal damage in the spontaneously hypertensive rats. Hypertension 21:975-979, 1993
35. TANAKA R, KON V, YOSHIOKA T, ICHIKAWA I, FOGO A: Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Kidney Int 45:537-543, 1994
36. HUTCHINSON FN, WEBSTER SK: Effect of Ang II receptor antagonist on albuminuria and renal function in passive Heymann nephritis. Am J Physiol 263:F311-F318, 1992
37. JOHNSTON CI: Angiotensin receptor antagonist: Focus on losartan. Lancet 346:1403-1407, 1995
38. ENG E, VENIANT M, FLOEGE J, FINGERLE J, ALPERS CE, MENARD J, CLOZEL JP, JOHNSON RJ: Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension. Am J Hypertens 7:177-185, 1994
39. NATHAN CF: Secretory products of macrophages. J Clin Invest 79:319-326, 1987
40. ONG ACM, FINE LG: Loss of glomerular function and tubulointerstitial fibrosis: Cause or effect? Kidney Int 45:345-351, 1994
41. NICOLIC-PATERSON DJ, LAN HY, HILL PA, ATKINS RC: Macrophages in renal injury. Kidney Int 45(Suppl 45):S79-S82, 1994
42. GIACHELLI CM, PICHLER R, LOMBARDI D, DENHARDT DT, ALPERS CE, SCHWARTZ SM, JOHNSON RJ: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 45:515-524, 1994
43. COUSER WG, JOHNSON RJ: Mechanisms of progressive renal disease in glomerulonephritis. Am J Kidney Dis 23:193-198, 1994
44. EL NAHAS AM: Renal scarring: The role of angiotensin II. Nephrol Dial Transplant 10(Suppl 9):28-32, 1995
45. JOHNSON RJ, ALPERS CE, YOSHIMURA A, LOMBARDI D, PRITZL P, FLOEGE J, SCHWARTZ SM: Renal injury from angiotensin II mediated hypertension. Hypertension 19:464-474, 1992
46. MUJAIS SK, KAUFFMAN S, KATZ AL: Angiotensin II binding sites in individual segments of the rat nephron. J Clin Invest 77:315-318, 1986
47. ONG ACM, FINE LG: Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: Implications for human renal disease progression. Am J Kidney Dis 23:205-209, 1994
48. NAGAMI GT: Effect of angiotensin II on ammonia production by isolated perfused mouse proximal tubules. (abstract) Kidney Int 35: 460, 1989
49. CHOBANIAN MC, JULIN CM: Angiotensin II stimulates ammoniagenesis in canine renal proximal tubules segments. Am J Physiol 260:F19-F26, 1991
50. NATH KA, HOSTETTER MK, HOSTETTER TH: Increased ammoniagenesis as a determinant of progressive renal injury. Am J Kidney Dis 17:654-657, 1991
51. NATH KA, HOSTETTER MK, HOSTETTER TH: Pathophysiology of chronic tubulo-interstitial disease in rats: interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 76:667-675, 1985
52. ICHIKAWA I: Will angiotensin II receptor antagonists be renoprotective in humans? Kidney Int 50:684-692, 1996